Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Premiums	$ 64,491	$ 56,967	$ 192,457	$ 168,686
Investment and other income	513	503	1,175	1,511
Total revenues	80,894	72,337	241,375	213,854
Operating costs:
Medical costs	52,635	47,302	157,251	138,752
Operating costs	11,663	10,725	34,773	31,307
Cost of products sold	8,306	7,802	25,389	23,034
Depreciation and amortization	828	796	2,418	2,332
Total operating costs	73,432	66,625	219,831	195,425
Earnings from operations	7,462	5,712	21,544	18,429
Interest expense	(516)	(422)	(1,416)	(1,229)
Earnings before income taxes	6,946	5,290	20,128	17,200
Provision for income taxes	(1,562)	(1,099)	(4,397)	(3,659)
Net earnings	5,384	4,191	15,731	13,541
Earnings attributable to noncontrolling interests	(122)	(105)	(372)	(327)
Net earnings attributable to UnitedHealth Group common shareholders	$ 5,262	$ 4,086	$ 15,359	$ 13,214
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic	$ 5.63	$ 4.33	$ 16.37	$ 14.00
Diluted	$ 5.55	$ 4.28	$ 16.15	$ 13.82
Basic weighted-average number of common shares outstanding	935	943	938	944
Dilutive effect of common share equivalents	13	12	13	12
Diluted weighted-average number of common shares outstanding	948	955	951	956
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	3	1	3	2
Products
Revenue from Products and Services	$ 9,190	$ 8,703	$ 28,026	$ 25,476
Services
Revenue from Products and Services	$ 6,700	$ 6,164	$ 19,717	$ 18,181

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227